Adicet Bio, Inc. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/74856142-9d30-49fc-8934-e4b8635c4175/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-122.1M | 2025-01-01 – 2025-12-31 | evidence 0001720580-26-000008 |
| FY 2024 | $-127.6M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-034587 |
| FY 2023 | $-152.0M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-033482 |
| FY 2022 | $-72.6M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-008130 |
| FY 2021 | $-61.4M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003753 |
| FY 2020 | $-39.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012664 |
| FY 2019 | $-31.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-012664 |
| FY 2018 | $-15.0M | 2018-01-01 – 2018-12-31 | evidence 0001564590-21-012664 |
| FY 2017 | $-18.9M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-008262 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).